Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway-Reference-Cited by-同舟云学术

Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway

Published:2014-11-20 Issue:1 Volume:16 Page:106-114
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Chen Ting,Wang Changyuan,Liu Qi,Meng Qiang,Sun Huijun,Huo Xiaokui,Sun Pengyuan,Peng Jinyong,Liu Zhihao,Yang Xiaobo,Liu Kexin

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/15384047.2014.987062

Reference48 articles.

1. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

2. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

3. P-glycoprotein: from genomics to mechanism

4. Multidrug resistance in cancer: role of ATP–dependent transporters

5. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutathione‐Sensitive Photosensitizer–Drug Conjugates Target the Mitochondria to Overcome Multi‐Drug Resistance in Cancer;Advanced Science;2024-06-19

2. Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway;Cellular Signalling;2024-05

3. Graphene Quantum Dots Eradicate Resistant and Metastatic Cancer Cells by Enhanced Interfacial Inhibition;Advanced Healthcare Materials;2024-04-17

4. Qualifying P-glycoprotein in drug-resistant ovarian cancer cells: a dual-mode aptamer probe approach;The Analyst;2024

5. Inhibition of Autophagy and the Cytoprotective Role of Smac Mimetic against ROS-Induced Cancer: A Potential Therapeutic Strategy in Relapse and Chemoresistance Cases in Breast Cancer;Current Issues in Molecular Biology;2023-07-10